Arthrex ACP®
The Next Generation PRP
100% Autologous, Pain-Free, and FDA-Approved
Arthrex ACP® (Autologous Conditioned Plasma) is a next-generation PRP system engineered to deliver high-quality platelet-rich plasma with a consistent and validated concentration of growth factors—without the use of anticoagulants. Designed as a closed, sterile system, Arthrex ACP® ensures safety, reproducibility, and superior clinical outcomes across regenerative and aesthetic applications.
This FDA-approved PRP technology produces plasma with uniform platelet distribution, allowing a gradual and sustained release of growth factors that supports tissue regeneration, collagen synthesis, and long-term healing—often with fewer sessions than conventional PRP systems.
Key Benefits & Features
· Minimally painful PRP procedure with no anticoagulant
· Delivers a higher concentration of platelets and growth factors
· Enables gradual, sustained growth factor release for longer-lasting results
· Promotes tissue regeneration, collagen production, and wound healing
· Requires fewer treatment sessions compared to conventional PRP
· FDA-approved, sterile, and contamination-free system
· Closed PRP system – maintains sterility from blood extraction to injection
· High yield output – 6–6.5 ml plasma (≈30% more than conventional PRP tubes)
· Validated platelet concentration – approximately 2.5× fold enrichment
· Even platelet distribution – no PPP, no buffy coat, uniform growth factor delivery
· Demonstrates superior histological, regenerative, and aesthetic outcomes
Clinical Indications
· Facial rejuvenation (nasolabial folds, crow’s feet, periorbital region)
· Hair restoration therapy – Androgenetic Alopecia – Alopecia Areata – Alopecia Barbae
· Hand and foot rejuvenation
· Wound healing and non-healing ulcers
· Scar treatment and dermal augmentation
· Stretch marks (striae)
Recommended Protocol
· 3 sessions of ACP-PRP, spaced 1 month apart, for optimal regenerative and aesthetic outcomes
· Protocol may be individualized based on clinical indication and physician discretion
SAFETY
Certified as a medical device, the Arthrex ACP double syringe offers a closed, sterile, needle-free system for use in the practice or operating theater.
MADE IN GERMANY
- The Arthrex ACP double syringe is manufactured in Germany.
- A quality management system in accordance with DIN ISO 13485 is in place for quality assurance.
EFFICIENT AND QUICK
- 15 ml of whole blood yields approximately 5-6 ml of PRP.
- The whole process takes 20 mins.